JACN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Altaf, W.
Right arrow Articles by Wapnir, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altaf, W.
Right arrow Articles by Wapnir, R. A.

Zinc Supplementation in Oral Rehydration Solutions: Experimental Assessment and Mechanisms of Action

Waseem Altaf, MD, Shahana Perveen, MD, Khalil U. Rehman, MD, Saul Teichberg, PhD, Ivana Vancurova, PhD, Rita G. Harper, MD, FACN and Raul A. Wapnir, PhD, FACN, CNS

Department of Pediatrics, Division of Neonatal/Perinatal Medicine, North Shore-Long Island Jewish Health System, Manhasset, New York



View larger version (31K):

[in a new window]
 
Fig. 1. NOS activity obtained from intestinal homogenates of rats fed either a normal, zinc-sufficient diet; a zinc-deficient diet for three weeks, prior to and after being given five days of cathartic solution; after cathartic treatment and recovery with ORS without zinc (-Zn) or with 1 mM zinc (+Zn); and zinc-deficient rats not exposed to cathartic, but given either ORS for two days. The error brackets indicate the SEM. The number of animals is that of Tables 1 and 2. {dagger} Indicates a significant difference (p < 0.05) respect of all other groups.

 


View larger version (27K):

[in a new window]
 
Fig. 2. Cecal nitrate plus nitrite content of the treatment groups described for Fig. 1. {dagger} Indicates a significant difference (p < 0.05) in respect to all other groups. * Denotes p < 0.05 between the cathartic-treated and not treated rats, after recovery with ORS, combining the results of those animals consuming fluids with or without zinc. The number of rats in each group is indicated in the tables.

 


View larger version (77K):

[in a new window]
 
Fig. 3. Intestinal villi from rats after two days in recovery from cathartic-induced diarrhea with ORS without zinc (a) or with zinc (b). Note the expansion of the intercellular space in the specimen (b). Magnification: 160x.

 


View larger version (119K):

[in a new window]
 
Fig. 4. Electrophoretic mobility assay shift (EMSA) of NF-{kappa}B from specimens obtained from zinc-deficient, cathartic-treated rats which recovered with an ORS with zinc (Zn +) and from rats which received ORS without zinc (Zn -). The areas corresponding a NF-{kappa}B mobility show a significantly greater DNA binding activation in the Zn- rats (densitometry readings: 53.2, 57.2) than in the Zn+ samples (32.1, 48.2). Details of the technique are given in the text.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Nutrition.